Analytic Investors’s NeoGenomics NEO Stock Holding History

Analytic Investors’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$1.31M	Buy	159,805 +25,206	+19%	+$211K	0.01%	333
2016 Q2	$1.08M	Sell	134,599 -64,547	-32%	-$517K	0.01%	367
2016 Q1	$1.34M	Buy	199,146 +89,513	+82%	+$589K	0.02%	363
2015 Q4	$863K	Hold	109,633	–	–	0.01%	420
2015 Q3	$628K	Buy	+109,633	New	+$679K	0.01%	426

Other funds holding NEO

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

CRC

Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Analytic Investors's NEO Position: Q3 2016 in Review

Analytic Investors increased its NeoGenomics (NEO) stake by 19% in Q3 2016, buying an estimated $211K and bringing the position to 159,805 shares worth $1.31M. The position accounts for 0.01% of the portfolio, ranked #333.

Analytic Investors first reported a position in NEO in Q3 2015 and has held it in 5 quarters since. The position peaked at $1.34M in Q1 2016. 137 funds tracked by Wall St. Rank hold NEO as of Q3 2016.

Analytic Investors held 159,805 shares of NeoGenomics worth $1.31M as of Q3 2016.
Analytic Investors bought 25,206 NeoGenomics shares in Q3 2016, an estimated $211K.
NeoGenomics made up 0.01% of Analytic Investors's portfolio in Q3 2016, its #333 holding.
Analytic Investors first reported a position in NeoGenomics in Q3 2015 and has held it in 5 quarters since.
Analytic Investors's NeoGenomics position peaked at $1.34M in Q1 2016.
137 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.